Home - Products - Others - Other Targets - [D-Ala2]-GRF (1-29) amide (human)

[D-Ala2]-GRF (1-29) amide (human)

CAS No. ———

[D-Ala2]-GRF (1-29) amide (human)( ——— )

Catalog No. M41196 CAS No. ———

[D-Ala2]-GRF (1-29) amide (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Ala2]-GRF (1-29) amide (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Ala2]-GRF (1-29) amide (human)
  • Description
    [D-Ala2]-GRF (1-29) amide (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    3356.95
  • Molecular Formula
    C149H245N44O42S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pomalidomide-PEG4-C2...

    Pomalidomide-PEG4-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.

  • Sennoside C

    Sennoside C is an anthraquinone glycoside extracted from leaves and pods of Senna and has an auxiliary effect on the laxative effect of mice.

  • Temozolomide Acid

    Temozolomide Acid is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.